Marrow ablative chemotherapy with hematopoietic stem cell rescue

Handbook of Brain Tumor Chemotherapy

Volumn , Issue , 2006, Pages 305-315

  Butturini, Anna ^a   Carabasi, Matthew ^a   Finlay, Jonathan L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883990627     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088410-0/50059-7     Document Type: Chapter

References (80)

1. Packer R.J., Goldwein J., Nicholson H.S., et al. Treatment of children with medulloblastoma with reduced dose craniospinal radian therapy and adjuvant chemotherapy. A Children's Cancer Study. J Clin Oncol 1999, 17:2127-2138.
2. Finlay J.L. The role of high dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant 1996, 18(suppl 3):S1-S5.
3. Gale R.P., Butturini A., Horowitz M.M. What is the best strategy fot autotransplants in cancer. Bone Marrow Transplant 1992, 9:303-309.
4. Kalifa C., Hartmann O., Demeocq F., et al. High dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 1992, 9:227-233.
5. Finlay J.L., Goldman S., Wong M.C., et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol 1996, 14:2495-2503.
6. Mahoney D.H., Strother D., Camitta B., et al. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol 1996, 14:382-388.
7. Dupuis Girod S., Hartmann O., Benhamou E., et al. Will high-dose chemotherapy followed by autologous bone marrow transplantation supplant craniospinal irradiation in young children treated for medulloblastoma. Journal of Neurooncol 1996, 27:87-98.
8. Grill J., Kalifa C., Doz F., et al. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Pediatr Neurosurg 1996, 25:7-12.
9. Bouffet E., Mottolese C., Jouvet A., et al. Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomas. Eur J Cancer 1997, 33:91-95.
10. Graham M.L., Herndon J.E., Casey J.R., et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997, 15:1814-1823.
11. Mason W.P., Grovas A., Halpern S., et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 1998, 16:210-221.
12. Mason W.P., Goldman S., Yates A.J., Boyett J., Li H., Finlay J.L. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma- a report of the Children's Cancer Group. J Neurooncol 1998, 37:135-143.
13. Dunkel I.J., Boyett J.M., Yates A., et al. High dose carboplatin, thiotepa and etoposide with autologous stem cell rescue for children with recurrent medulloblastoma. Children's Cancer Group. J Clin Oncol 1998, 16:222-228.
14. Dunkel I.J., Garvin J.H., Goldman S., et al. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. J Neurooncol 1998, 37:67-73.
15. Guruangan S., Dunkel I.J., Goldman S., et al. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol. 1998, 16:2486-2493.
16. Papadopoulos K.P., Garvin J.H., Fetell M., et al. High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults. Bone Marrow Transplant 1998, 22:661-667.
17. Grovas A.C., Boyett J.M., Lindsey K., et al. Regimen related toxicity of myeloablative chemotherapy with BCNU, thiotepa and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group. Med Ped Oncol 1999, 33:83-87.
18. Abrey L.E., Rosenblum M.K., Papadopoulos E., et al. High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors. J Neurooncol 1999, 147-153.
19. Henon P.R., Butturini A., Gale R.P. Blood derived hematopoietic stem cell transplants: blood to blood. Lancet 1991, 337:961-963.
20. Jakacki R.I., Jamison C., Mathews V.P., et al. Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Med Ped Oncol 1998, 31:483-490.
21. Yule S.M., Foreman N.K., Mitchell C., Gouldon N., May P., McDowell H.P. High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study. J Clin Oncol 1997, 15:3258-3265.
22. Gajjar A., Chintagumpala M., Kellie S., et al. Excellent event free survival in newly diagnosed high risk medulloblastoma treated with craniospinal radiation therapy followed by 4 cycles of high dose chemotherapy and stem cell rescue: results of a prospective multicenter trial. Abstract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 147.
23. Vassal G., Tranchand B., Valteau-Couanet D., et al. Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma. Bone Marrow Transplant 2001, 27:471-477.
24. Foreman N., Handler, Schissel D., et al. A study of sequential high dose cyclophosphamide and high dose carboplatin with peripheral stem cell rescue in resistant or recurrent pediatric brain tumors. Astract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 145.
25. Zia M.I., Forsyth P., Chaudhry A., Russell J., Stewart D.A. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma. Bone Marrow Transplant 2002, 30:565-569.
26. Picton S., Robinson K., Weston C., et al. A UKCCSG study of the treatment of relapsed CNS primitive neuroectodermal tumors using high dose chemotherapy. Abstract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 169.
27. Ascensao J., Ahmed T., Feldman E., et al. High dose thiotepa with autologous bone marrow transplantation and localized radiotherapy for patients with astrocytoma grade II-IV: a promising approach. Proc Am Soc Clin Oncol 1989, 21:1023. abstract.
28. Kushner B.H., Cheung N.K., Kramer K., Dunkel I.J., Calleja E., Boulad F. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults. Bone Marrow Transplant 2001, 28:551-556.
29. Bouffet E., Raquin M., Doz F., et al. Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 2000, 88:685-692.
30. Kedar A., Maria B.L., Graham Pole J., et al. High dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high risk brain tumors. Bone Marrow Transplant 1994, 23:428-436.
31. Phillips G.l., WolffS.N., Fay J.W. Intensive 1,2 bis (2chloroethyl) 1nitrosorea (BCNU) monotherapy and autologous bone marrow transplantation for malignant glioma. J Clin Oncol 1986, 4:639-645.
32. Fernandez-Hidalgo O.A., Vanaclocha V., Vieitez J.M., et al. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients. Bone Marrow Transplant 1996, 18:143-149.
33. Calvert A.H., Newell D.R., Gumbrell L.A., et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989, 71:1748-1756.
34. Faulkner L.B., Lindsley K.L., Kher U., Heller G., Black P., Finlay J.L. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery. Bone Marrow Transplant 1996, 17:389-394.
35. Kramer E.D., Packer R.J., Ginsberg J., et al. Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors. Pediatr Neurosurg 1997, 27:230-237.
36. Freilich R.J., Kraus D.H., Budnick A.S., Bayer L.A., Finlay J.L. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Ped Oncol 1996, 26:95-100.
37. Sands S.A., van Gorp W.G., Finlay J.L. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Childs Nerv System 1998, 14:87-89.
38. Baker K.S., DeFor T.E., Burns L.J., Ramsay N.K., Neglia J.P., Robison L.L. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 2003, 21:1352-1358.
39. Brennan B.M., Shalet S.M. Endocrine late effects after bone marrow transplant. Br J Haematol 2002, 118:58-66.
40. Ashley D.M., Longee D., Tien R., et al. Treatment of patients with pineoblastoma with high dose cyclophosphamide. Med Pediatric Oncol 1996, 26:387-392.
41. Fagioli F., Biasin E., Mastrodicasa L., et al. High dose thiotepa and etoposide in children with poor prognosis brain tumors. Cancer 2004, 100:2215-2221.
42. Broniscer A., Nicolaides T.P., Dunkel I.J., et al. High-dose chemotherapy with autologous stem cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Ped Blood Cancer 2004, 4:261-267.
43. Ridola V., Doz F., Frappaz D. High dose chemotherapy and posterior fossa radiotherapy for children less then 3-5 years with localized high risk medulloblastoma at diagnosis or at relapse. The SFOP experience. Astract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 171.
44. Finlay J.L., Allen J., Kellie S., et al. Survival after intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous stem cell rescue in young children newly diagnosed with non-cerebellar PNET. The Head Start Regimen. Proc Am Soc Clin Oncol 2003, 22:804. abstract.
45. Grodman H.M., Gardner S., Gardner S., Dunkel I., et al. Outcome of children less then three years old diagnosed with non metastatic medulloblastoma treated with chemotherapy on Head Start I and II protocols. Proc Am Soc Clin Oncol 2003, 22:804. abstract.
46. Hilden J.M., Meerbaum S., Burger P., et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004, 22:2877-2884.
47. Gardner S., Diez B., Green A., et al. Intensive induction chemotherapy followed by high dose chemotherapy with autologous stem cell rescue (ASCR) in young children newly diagnosed with central nervous system (CNS) atypical teratoid rhabdoid tumors (ATT/RT). The head start regimen. Abstract,, International Symposium of Pediatric Neurooncology(ISPNO) Meeting 2004, 1148.
48. Stewart L.A. Chemotherapy in adult high grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002, 359:1011-1018.
49. Jaeckle K.A., Hess K.R., Yung W.K., et al. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol 2003, 21:2305-2311.
50. Balmaceda C., Fetell M.R., Hesdorffer C. Thiotepa and etoposide treatment of recurrent malignant gliomas: phase I study. Cancer Chemother Pharmacol 1997, 40:72-74.
51. McCowage G.B., Friedman H.S., Moghrabi A., et al. Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas. Med Ped Oncol 1998, 30:75-80.
52. Bottom K.S., Ashley D.M., Friedman H.S., Longee D.C. Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme. Writing Committee for the Brain Tumor Center at Duke. J Neurooncol 2000, 46:151-156.
53. Jakacki R.I., Jamison C., Heifetz S.A., Caldemeyer K., Hanna M., Sender L. Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies. Med Ped Oncol 1997, 29:553-559.
54. Jakacki R.I., Siffert J., Jamison C., Velasquez L., Allen J.C. Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neurooncol 1999, 44:77-83.
55. Biron P., Vial C., Chauvin F., et al. Strategies including surgery, high dose BCNU followed by ABMT and radiotherapy in supratentorial high grade astrocytoma. A report of 98 patients. In Autologous bone marrow transplantation: Proceeding of the First International Symposium 1985, 227-230. University of Texas 1985, Philadelphia. K.A. Dicke, J.O. Spitzer, M.J. Dicke Evinger (Eds.).
56. Durando X., Lemaire J.J., Tortochaux J., et al. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Bone Marrow Transplant 2003, 31:559-564.
57. Linassier C., Destrieux C., Benboubker L. Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma. Bull Cancer 2001, 88:871-876.
58. Brandes A.A., Palmisano V., Pasetto L.M., Basso U., Monfardini S. High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults. Cancer Invest 2001, 19:41-48.
59. Bouffet E., Khelfaoui F., Philip I., Biron P., Brunat-Mentigny M., Philip T. High-dose carmustine for high-grade gliomas in childhood. Cancer Chemother Pharmacol 1997, 39:376-379.
60. Finlay J.L., August C., Packer R., et al. High dose multiagent chemotherapy followed by bone marrow rescue for malignant astrocytoma of childhood and adolescence. J Neurooncol 1990, 9:239-248.
61. Heideman R.L., Douglass E.C., Krance R.A., et al. High dose chemotherapy and autologous bone marrow rescue followed by interstitial and external beam radiotherapy in new diagnosed pediatric malignant glioma. J Clin Oncol 1993, 11:1456-1465.
62. Abrey L.E., Childs B.H., Paleologos N., et al. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. J Neuroncol 2003, 65:127-134.
63. Cairncross G., Macdonald D., Ludwin S., et al. Chemotherapy for anaplastic oligodedroglioma. J Clin Oncol 1994, 12:2013-2021.
64. Gumley D., Phipps K., Reynolds J., Michalski A. Infants with ependymoma: outcome following surgery and baby brain chemotherapy. Astract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 152.
65. Levy A.S., Gardner S., Brady K., et al. Outcome of young children with newly diagnosed ependymoma treated with intensive induction chemotherapy followed by myeloablative consolidative chemotherapy with autologous stem cell rescue. Proc Am Soc Clin Oncol 2003, 22:804. abstract.
66. Modak S., Gardner S., Dunkel I.J., et al. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 2004, 22:1934-1943.
67. Lundberg J.H., Weissman D.E., Beatty P.A., Ash R.C. Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. J Neurooncol 1992, 13:151-155.
68. Tanaka M., Shibui S., Kobayashi Y., Nomura K., Nakanishi Y. A graft-versus-tumor effect in a patient with ependymoma who received an allogeneic bone marrow transplant for therapy-related leukemia. Case report. J Neurosurg 2002, 97:474-476.
69. Takada S., Ito K., Sakura T., et al. Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations. Bone Marrow Transplant 1999, 23:731-734.
70. Kasow K.A., Handgretinger R., Krasin M., et al. Possible allogeneic graft-versus-tumor effect in childhood melanoma. J Pediatr Hematol Oncol 2003, 25:982-986.
71. Aoyama Y., Yamamura R., Shima E., et al. Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma. Ann Hematol 2003, 82:371-373.
72. Varadi G., Or R., Kapelushnik J., et al. Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk Lymphoma 1999, 34:185-190.
73. Hentschke P., Barkholt L., Uzunel M., et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant 2003, 31:253-261.
74. Ueno N.T., Cheng Y.C., Rondon G., et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood 2003, 102:3829-3836.
75. Glick R.P., Lichtor T., Panchal R., et al. Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors. J Neurooncol 2003, 64:139-146.
76. Blackett N.M., Millard R.E. Differential effect of Myleran on two normal haemopoietic progenitor cell populations. Nature 1973, 244:300-301.
77. Ellis G.K., Livingston R.B., Gralow J.R., Green S.J., Thompson T. Dose-dense anthracycline-based chemotherapy for node-positive breast cancer. J Clin Oncol 2002, 20:3637-3643.
78. Frank S., Muller J., Bonk C., Haroske G., Schackert H.K., Schackert G. Transmission of glioblastoma multiforme through liver transplantation. Lancet 1998, 352:31.
79. Gardner S., Baker D., Belasco J., et al. Phase I dose escalation of temozolomide with thiotepa and carboplatin with autologous stem cell rescue in patients with recurrent/refractory central nervous system tumors. Abstract, International Symposium of Pediatric Neurooncology (ISPNO) Meeting 2004, 47.
80. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999, 341:1165-1173.